Amyotrophic lateral sclerosis (ALS) is an incapacitating neuromuscular disease of unknown etiology. Although laboratory evidence is lacking, circumstantial evidence supports the importance of immune factors in the pathogenesis of ALS. In the present study immunoglobulins from 4 of 8 ALS patients induced a significant increase in spontaneous quantal transmitter release as monitored by miniature end-plate potential (MEPP) frequency in mouse phrenic nerve-diaphragm preparations at 23TC, whereas immunoglobulins from normal individuals and from patients with other neuromuscular diseases had no effect. At 320C neither normal nor disease control immunoglobulins influenced MEPP frequency, but 8 of 11 ALS immunoglobulin samples produced a significant increase in spontaneous quantal transmitter release. The enhancing effect could be prevented by 10 mM Mg2". No effects were noted on MEPP amplitude and muscle resting potential. These findings suggest that the presynaptic terminal of the motor neuron may be an early target and that immunological factors may play an important role in the disease process.Amyotrophic lateral sclerosis (ALS) is a relentless incapacitating neuromuscular disease characterized by selective degeneration of lower and upper motor neurons. Despite intensive investigation, the etiology is unknown and effective therapy is lacking. Viruses (1-3), toxins (4), impaired aging (5), and altered tropic-factor function (6) have been implicated but not proven. There are no convincing laboratory demonstrations of specific antibodies in ALS. Recent attempts with cultured spinal neurons have been unsuccessful in documenting that ALS serum affects either cholinergic activity (7) or neurofilament protein expression (8). Furthermore, efforts to replicate binding of ALS serum globulins to a muscle protein have been unsuccessful using the recombinantly synthesized protein or the original extraction process (9-11).However, autoimmunity still remains likely because of the increased incidence of associated autoimmune disorders (12) and the increased frequency of paraproteinemias (13) in ALS patients. Because of such circumstantial clinical evidence, we have continued our search for antibodies in ALS. We have investigated the effects of ALS immunoglobulins on spontaneous transmitter release in mouse phrenic nervediaphragm preparations. The present report provides evidence that immunoglobulins from ALS patients can alter spontaneous transmitter release from motor neurons in this in vitro assay system.
MATERIALS AND METHODSThe experiments were performed with hemidiaphragms dissected after cervical dislocation from male BALB/c or Swiss mice weighing 25-30 g. The muscle was pinned to a small disc of Sylgard, which then was placed in an incubation chamber containing 5-10 ml of Krebs-Ringer solution (137 mM NaCl/5 mM KCI/2 mM CaCl2/1 mM MgSO4/12 mM Na-HCO3/1 mM NaH2PO4/11 mM glucose, pH 7.4). The solution was oxygenated by continuous bubbling with a mixture of 5% CO2 and 95% 02. After the muscle was rinsed several times wi...